Imprimis Receives FDA Warning Over Eye Medication Advertising Imprimis Receives FDA Warning Over Eye Medication Advertising

The U.S. Food and Drug Administration has issued a warning letter to Imprimis Pharmaceuticals Inc accusing it of making false or misleading claims that its compounded eye medications had the agency ' s approval.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Source Type: news